PL2520575T3 - Związek 1,3,4-oksadiazolo-2-karboksyamidowy - Google Patents
Związek 1,3,4-oksadiazolo-2-karboksyamidowyInfo
- Publication number
- PL2520575T3 PL2520575T3 PL10841060T PL10841060T PL2520575T3 PL 2520575 T3 PL2520575 T3 PL 2520575T3 PL 10841060 T PL10841060 T PL 10841060T PL 10841060 T PL10841060 T PL 10841060T PL 2520575 T3 PL2520575 T3 PL 2520575T3
- Authority
- PL
- Poland
- Prior art keywords
- oxadiazole
- carboxamide compound
- carboxamide
- compound
- Prior art date
Links
- -1 1,3,4-oxadiazole-2-carboxamide compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009297960 | 2009-12-28 | ||
| EP10841060.6A EP2520575B1 (en) | 2009-12-28 | 2010-12-28 | 1,3,4-oxadiazole-2-carboxamide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2520575T3 true PL2520575T3 (pl) | 2017-05-31 |
Family
ID=44226607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10841060T PL2520575T3 (pl) | 2009-12-28 | 2010-12-28 | Związek 1,3,4-oksadiazolo-2-karboksyamidowy |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8796320B2 (pl) |
| EP (1) | EP2520575B1 (pl) |
| JP (1) | JP5794922B2 (pl) |
| KR (1) | KR101778320B1 (pl) |
| CN (1) | CN102725287B (pl) |
| AU (1) | AU2010339271B2 (pl) |
| CA (1) | CA2785679C (pl) |
| EA (1) | EA022458B1 (pl) |
| ES (1) | ES2610248T3 (pl) |
| NZ (1) | NZ600837A (pl) |
| PL (1) | PL2520575T3 (pl) |
| TW (1) | TWI523851B (pl) |
| WO (1) | WO2011081205A1 (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ767139A (en) | 2009-12-04 | 2022-08-26 | Sunovion Pharmaceuticals Inc | Multicyclic compounds and methods of use thereof |
| EP2718279B1 (en) | 2011-06-09 | 2016-08-10 | Rhizen Pharmaceuticals SA | Novel compounds as modulators of gpr-119 |
| US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
| UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
| WO2017013270A1 (en) | 2015-07-23 | 2017-01-26 | Universite De Strasbourg | Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy |
| WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| PT3494119T (pt) | 2016-07-29 | 2024-12-10 | Pgi Drug Discovery Llc | Compostos e composições e seus usos |
| CN110087687A (zh) | 2016-07-29 | 2019-08-02 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
| CN109715163B (zh) | 2016-09-19 | 2022-11-22 | 诺华股份有限公司 | 包含raf抑制剂和erk抑制剂的治疗组合 |
| CN110678205B (zh) | 2017-02-16 | 2023-05-23 | 桑诺维恩药品公司 | 治疗精神分裂症的方法 |
| WO2018187479A1 (en) | 2017-04-04 | 2018-10-11 | Case Western Reserve University | Method of modulating ribonucleotide reductase |
| TWI798218B (zh) | 2017-05-02 | 2023-04-11 | 瑞士商諾華公司 | 組合療法 |
| KR20200036008A (ko) | 2017-08-02 | 2020-04-06 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로만 화합물 및 이의 용도 |
| CN109535146B (zh) * | 2017-09-21 | 2020-09-22 | 中国医学科学院医药生物技术研究所 | 抗结核化合物及其制备方法和用途 |
| EA202091945A1 (ru) | 2018-02-16 | 2021-01-18 | Суновион Фармасьютикалз Инк. | Соли, кристаллические формы и способы их получения |
| TWI826531B (zh) | 2018-09-21 | 2023-12-21 | 南韓商愛思開生物製藥股份有限公司 | 具有㗁二唑之化合物及包含該化合物之醫藥組合物 |
| CN113874015B (zh) | 2018-12-21 | 2024-05-24 | 细胞基因公司 | Ripk2的噻吩并吡啶抑制剂 |
| US11447482B1 (en) | 2019-02-14 | 2022-09-20 | KUDA Therapeutics, Inc. | Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of HIF-2A pathway inhibition, and induction of ferroptosis |
| AU2020236225B2 (en) | 2019-03-14 | 2025-12-18 | Sumitomo Pharma America, Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| SG11202110829YA (en) | 2019-04-05 | 2021-10-28 | Kymera Therapeutics Inc | Stat degraders and uses thereof |
| EP4563150A3 (en) | 2019-05-13 | 2025-07-23 | Novartis AG | New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl) isonicotinamide as raf inhibitors for the treatment of cancer |
| AU2020321956A1 (en) | 2019-07-31 | 2022-03-10 | Boehringer Ingelheim International Gmbh | Heterobicyclic amides as inhibitors of CD38 |
| US12344589B2 (en) * | 2019-09-09 | 2025-07-01 | Elobix Ab | Method for producing a 1,5-benzothiazepin compound |
| MX2022012833A (es) | 2020-04-14 | 2022-11-07 | Sunovion Pharmaceuticals Inc | (s)-(4,5-dihidro-7h-tieno[2,3-c]piran-7-il)-n-metilmetanamina para tratar trastornos neurologicos y psiquiatricos. |
| WO2022216930A1 (en) * | 2021-04-08 | 2022-10-13 | Virginia Commonwealth University | Novel mda-9 antagonist with anti-metastatic potential |
| WO2024141004A1 (en) * | 2022-12-31 | 2024-07-04 | Nanjing Immunophage Biotech Co., Ltd | Compounds as inhibitors of macrophage migration inhibitory factor and the use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7429593B2 (en) * | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| EP1501829B1 (en) | 2002-05-06 | 2010-11-24 | Vertex Pharmaceuticals Incorporated | Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| US7683097B2 (en) * | 2004-05-27 | 2010-03-23 | Propharmacon Inc. | Topoisomerase inhibitors |
| EP1802606B1 (en) | 2004-10-19 | 2011-03-16 | Compass Pharmaceuticals LLC | Arylcarboxamides and their use as anti-tumor agents |
| UA95978C2 (ru) * | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| US9745278B2 (en) * | 2007-09-10 | 2017-08-29 | Boston Biomedical, Inc. | Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors |
| JP2011507910A (ja) * | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
| WO2009149192A1 (en) * | 2008-06-04 | 2009-12-10 | Baylor College Of Medicine | Stat3 inhibitors |
| NZ590355A (en) * | 2008-07-10 | 2013-01-25 | Yakult Honsha Kk | Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
-
2010
- 2010-12-28 PL PL10841060T patent/PL2520575T3/pl unknown
- 2010-12-28 US US13/519,707 patent/US8796320B2/en active Active
- 2010-12-28 CN CN201080059883.3A patent/CN102725287B/zh not_active Expired - Fee Related
- 2010-12-28 CA CA2785679A patent/CA2785679C/en active Active
- 2010-12-28 TW TW099146436A patent/TWI523851B/zh not_active IP Right Cessation
- 2010-12-28 EP EP10841060.6A patent/EP2520575B1/en active Active
- 2010-12-28 AU AU2010339271A patent/AU2010339271B2/en not_active Ceased
- 2010-12-28 JP JP2011547732A patent/JP5794922B2/ja not_active Expired - Fee Related
- 2010-12-28 KR KR1020127016740A patent/KR101778320B1/ko not_active Expired - Fee Related
- 2010-12-28 EA EA201290397A patent/EA022458B1/ru not_active IP Right Cessation
- 2010-12-28 ES ES10841060.6T patent/ES2610248T3/es active Active
- 2010-12-28 NZ NZ600837A patent/NZ600837A/en not_active IP Right Cessation
- 2010-12-28 WO PCT/JP2010/073787 patent/WO2011081205A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP5794922B2 (ja) | 2015-10-14 |
| AU2010339271A1 (en) | 2012-07-19 |
| NZ600837A (en) | 2014-01-31 |
| AU2010339271B2 (en) | 2015-09-03 |
| CA2785679A1 (en) | 2011-07-07 |
| CA2785679C (en) | 2017-12-12 |
| WO2011081205A1 (ja) | 2011-07-07 |
| CN102725287A (zh) | 2012-10-10 |
| TW201127832A (en) | 2011-08-16 |
| EP2520575A1 (en) | 2012-11-07 |
| ES2610248T3 (es) | 2017-04-26 |
| TWI523851B (zh) | 2016-03-01 |
| US8796320B2 (en) | 2014-08-05 |
| US20120302524A1 (en) | 2012-11-29 |
| EA201290397A1 (ru) | 2013-01-30 |
| KR101778320B1 (ko) | 2017-09-13 |
| CN102725287B (zh) | 2015-07-01 |
| EP2520575A4 (en) | 2013-12-11 |
| EA022458B1 (ru) | 2016-01-29 |
| EP2520575B1 (en) | 2016-11-30 |
| KR20120109530A (ko) | 2012-10-08 |
| JPWO2011081205A1 (ja) | 2013-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2520575T3 (pl) | Związek 1,3,4-oksadiazolo-2-karboksyamidowy | |
| EP2361902A4 (en) | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG | |
| ZA201108962B (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 | |
| SI2384326T1 (sl) | Pirolo(2,3-d)pirimidinske spojine | |
| GB0913345D0 (en) | New combination 802 | |
| SI2356123T1 (sl) | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni | |
| GB0804989D0 (en) | Compound | |
| SI2513119T1 (sl) | 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati | |
| GB201203224D0 (en) | Substitute 1,2-azaborne heterocycles | |
| GB0900404D0 (en) | New compounds 4 | |
| GB0803494D0 (en) | Compound | |
| IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| SI2266990T1 (sl) | Spojina 3-fenilpirazolo(5,1-b)tiazola | |
| GB0912946D0 (en) | New compounds 5 | |
| AP2011005932A0 (en) | Pyrazinoisoquinoline Compounds. | |
| IL213762A0 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| GB201208654D0 (en) | Moisturing composition | |
| ZA201202652B (en) | Pesticidal compositions comprising 4,5-dihydroxyindan-1-one | |
| GB0823316D0 (en) | Compound | |
| GB0900385D0 (en) | Lasha2A.1 | |
| GB0918322D0 (en) | Compounds 814 | |
| GB0913344D0 (en) | Compounds 762 | |
| GB0912947D0 (en) | New compounds 6 | |
| GB0900400D0 (en) | New compounds 3 |